- Open Access
Prenatal diagnosis of Williams-Beuren syndrome by ultrasound and chromosomal microarray analysis
Molecular Cytogenetics volume 15, Article number: 27 (2022)
There are a few literature reports of prenatal ultrasound manifestations of Williams-Beuren syndrome. We aimed to explore the prenatal diagnosis of Williams-Beuren syndrome by ultrasound and chromosomal microarray analysis and describe the prenatal ultrasound performance of this syndrome.
In this retrospective study, we reported eight cases of Williams-Beuren syndrome diagnosed at our prenatal diagnostic center from 2016 to 2021. We systematically reviewed clinical data from these cases, including indications for invasive testing, sonographic findings, QF-PCR results, chromosomal microarray analysis results, and pregnancy outcomes.
In this study, the common ultrasound features were ventricular septal defect (37.5%), intrauterine growth retardation (25%), and aortic coarctation (25%). Moreover, all patients were found to have a common deletion in the Williams-Beuren syndrome chromosome region at the 7q11.23 locus, which contained the elastin gene. Deletion sizes ranged from 1.42 to 2.07 Mb. Seven parents asked for termination of pregnancy, and one patient was lost to follow-up.
This study is the most extensive prenatal study using chromosomal microarray analysis technology for detailed molecular analysis of Williams-Beuren syndrome cases. We reported three cases combined with first-reported ultrasound manifestations. Case 1 was concomitant with multicystic dysplastic kidney and duodenal atresia combined with case 3. Notably, case 4 was combined with multiple cardiovascular malformations: Tetralogy of Fallot, right aortic arch, and supravalvar aortic stenosis. These manifestations expand the intrauterine ultrasound phenotype of Williams-Beuren syndrome in previous literature reports.
Williams-Beuren syndrome (WBS; OMIM #194050), a multisystem disorder, is caused by a heterozygous microdeletion in the WBS chromosome region (WBSCR) on chromosome 7 at band 7q11.23 . Its incidence is about 1 in 10,000, more common in microdeletion syndrome . There is no apparent family inheritance pattern in WBS. In most cases, it is of sporadic origin, with no predilection for sex or ethnicity; the rare reported cases of familial occurrence suggest an autosomal dominant inheritance pattern .
The common deletion/duplication ranges from 1.55 to 1.84 Mb and spans approximately 26–28 genes . Elastin (ELN) haploinsufficiency in WBS results in an arteriopathy involving medium- and large-sized arteries leading to lumen narrowing. Furthermore, congenital cardiovascular defects are the most important and common cause of morbidity and death in 80% of patients with WBS [5,6,7].
WBS has a characteristic constellation of findings. The main clinical manifestations are as follows: facial appearance characteristics, growth retardation, cardiovascular diseases, infantile hypercalcemia, endocrine abnormalities, intellectual disability, and aberrant neurocognitive profile . Typical facial deformities include a small nose, hypoplastic nasal bridge, macrostomia, large and thick lips, prominent cheeks, a small chin, and periorbital fullness . Among endocrine abnormalities associated with WBS, Hypercalcemia is more common. However, there are also relevant literature reports of hypocalcemia . And the content of calcium may be related to the expression of the BAZ1B gene. The broad spectrum of clinical manifestations of this disease is related to the size of the deleted fragment and the function of the deleted genes.
About 6% of fetuses with abnormal ultrasonography and normal karyotype can identify clinically significant chromosomal variations through chromosome microarray (CMA) testing . Compared to fluorescence in situ hybridization (FISH) and multiplex ligation-dependent probe amplification (MLPA), CMA has high resolution and high accuracy at the whole genome level. CMA is not only suitable for identifying typical/atypical Copy Number Variations (CNVs) and refining the distal breakpoint for classical or nonclassical WBS but also can identify other potential pathogenic CNVs.
Due to the prenatal ultrasound features of WBS being incomplete and atypical, it is more difficult to diagnose it prenatally. Until now, approximately 22 cases prenatally diagnosed with WBS have been reported in the literature [10,11,12,13,14,15,16,17,18,19,20,21,22,23]. However, because the prognosis of WBS is very abysmal, we need to improve the detection rate and carry out the intrauterine intervention in time. Here we reported on eight other new cases of fetal WBS diagnosed by CMA to delineate the fetal presentation of this syndrome further. As we know, this study is the most extensive prenatal study using CMA technology for detailed molecular analysis of WBS cases.
This study was a retrospective one approved by our institutional review board/ethics committee, and informed consent from the patients’ legal representatives was not required. We reviewed consecutive prenatal cases of WBS diagnosed at the Prenatal Diagnosis Center, Guangzhou Women and Children's Medical Center from November 2016 to September 2021. We systematically reviewed clinical data from these cases, including maternal demographics, indications for invasive testing, sonographic findings, QF-PCR results, CMA results, and pregnancy outcomes.
This study included eight singleton pregnancies. Maternal age was 23–38 years, with an average of 30.88 years. At a median gestational age of 28.50 weeks, each patient underwent a routine ultrasound scan. All cases were scanned for fetal anatomy, and associated abnormalities were recorded. After ultrasound screening or genetic counseling, all gravidas underwent an invasive prenatal diagnosis at our hospital. Their initial amniocentesis indications included ultrasound abnormalities (case 1–8), poor fertility history (cases 3, 7, and 8), and advanced maternal age (case 5).
CMA replaced traditional karyotyping as the diagnostic approach for pregnancies with fetal structural anomalies at our center. With the written consent of the parents, amniotic fluid or fetal blood was sampled by amniocentesis or cordocentesis. Quantitative fluorescent polymerase chain reaction (QF-PCR) was used to detect common autosomal aneuploidies and was also used as a tool to detect maternal contamination. The CMA platform used was CytoScan 750 K Array (Affymetrix Inc., Santa Clara, CA, USA), containing 750,436 25-85-mer oligonucleotide probes, including 550,000 nonpolymorphic (NP) probes and 200,436 single nucleotide polymorphic (SNP) probes (0.1 Mb resolution). The process has been described in detail elsewhere . All patients were offered counseling by a maternal–fetal medicine team, including genetic counselors.
In this study, eight fetuses were diagnosed with WBS by CMA, and we reviewed the intrauterine ultrasound manifestations of these fetuses. Table 1 shows all the clinical features of these eight cases.
In our eight cases, the common ultrasound features were as follows: ventricular septal defect (VSD) (case 4, 5 and 8, 37.5%), intrauterine growth retardation (IUGR) (case 6 and 7, 25%), aortic coarctation (AC) (case 2 and 5, 25%), multicystic dysplastic kidney (MCDK) (case 1, 12.5%), duodenal atresia (DA) (case 3, 12.5%), pulmonary artery stenosis (PAS) (case 6, 12.5%), Tetralogy of Fallot (TOF) (case 4, 12.5%), right aortic arch (RAA) (case 4, 12.5%), SVAS (case 4, 12.5%). Figure 1 shows some typical ultrasound performance in these cases.
In all cases, the results of QF-PCR suggested that no abnormalities in the number of 21, 18, 13, and sex chromosomes were observed. And in our study, all fetuses were found to have a common deletion in the WBSCR at the 7q11.23 locus, which contained the ELN gene. Deletion sizes ranged from 1.42 to 2.07 Mb. This percentage was similar to previous findings.
After genetic counseling on their genomic test results, seven parents asked for termination of pregnancy, and one patient was lost to follow-up.
The current study has preliminarily explored the potential genetic mechanisms of WBS. The deletions in the WBS region arise due to interchromosomal or interchromatid and intrachromatid misalignment resulting in unequal crossing over between the areas comprising the low copy repeats blocks . Our study used CMA as a first-line test and detected eight clinically significant cases. To date, 30 fetuses with prenatal diagnoses of WBS have been reported.
In previous literature reports, the most common ultrasound features were: IUGR (82.35%), SVAS (40%), VSD (30%), AC (20%), and PAS (20%) . However, in our study, the incidence of IUGR (25%) and SVAS (12.5%) were lower than in previous studies. First, IUGR is almost always detected in the late second or third trimester; indeed, the median gestational age at which the diagnosis in our cohort was 28.50 weeks, and 50% (4/8) were in the second trimester, so the intrauterine manifestations of IUGR may not yet be present. Second, this may be due to the improved quality of ultrasound evaluation, and there are some fetal severe defects that can be detected in the first trimester. Moreover, together with the wide application of noninvasive prenatal testing-plus (NIPT-plus), which has high sensitivity and specificity, parents were likely to terminate these pregnancies before a detailed sonographic survey.
As previously reported in the literature, the common intrauterine phenotypes in our cohort were cardiovascular diseases. In addition to the common manifestations such as SVAS, VSD, and PAS, one case (case 4) was combined with TOF, the first-reported ultrasound presentation in a WBS fetus. Similar to previous reports in the literature, the expression of cardiovascular disease in WBS is highly variable, ranging from multiple cardiovascular malformations to no clinical manifestations of this system. Loss of an ELN allele is the single most crucial genetic change responsible for the cardiovascular problems of WBS . Due to this reason, decreased vascular elasticity may increase the hemodynamic stress on the endothelium, leading to intimal hyperplasia of smooth muscle and fibroblasts, fibrosis, and narrowing of the vascular lumen . However, the pathogenesis of arterial lesions in WBS may be more complex, and we think there may be other genes that may also be involved in regulating the cardiovascular system. The WBS phenotype may also be affected by the location of genes on both sides of the deletion. Further genetic analysis or epigenetic information is needed to understand the contribution of other genetic components to WBS cognition.
Patients with WBS may have abnormalities of the kidneys or urinary tract. Such as small kidney, renal agenesis, renal insufficiency, renal artery stenosis, bladder diverticula, etc. [4, 28, 29]. Furthermore, MCDK present in case 1 is also a congenital structural defect of the kidney. Among these genes within the commonly deleted interval, no known OMIM disease genes are known to cause urinary defects in fetuses yet. And among the endocrine abnormalities associated with WBS, hypercalcemia is the most common cause. Although various mechanisms have been proposed to cause hypercalcemia, none have been confirmed . We speculate that because of hypercalcemia-induced renal calcium deposits, this may be related to urinary defects, but this requires further experiments to verify.
In addition to the feeding problems and gastroesophageal reflux that occur in infancy, gastrointestinal problems in WBS include colon diverticulosis, inguinal and umbilical hernias, rectal prolapse, constipation, and chronic abdominal pain . Case 3 was combined with DA. The vast majority of cases of DA are sporadic, and it is unclear whether this abnormality is present coincidently or is indeed part of the phenotype of WBS. If the latter is the case, we speculate that it could be because of ELN haploinsufficiency, which may lead to the intimal proliferation of smooth muscle and fibroblasts . Hence, more studies are needed to ascertain the precise contribution of ELN or other genes to gastrointestinal problems.
There are some limitations to this study. First, because CMA confirmed the diagnosis of WBS, none of these 8 cases chose to continue with whole-exome sequencing or whole-genome sequencing, and seven decided to terminate the pregnancy to the extent that we cannot discuss it further. Second, we had no information about the CNVs of all patients' parents. Therefore, there was only some genetic information obtained related to CNVs.
In summary, our results suggest that the prenatal ultrasound findings in WBS are mainly characterized by IUGR combined with characteristic cardiovascular abnormalities, but the expression in the cardiovascular system is highly variable, so we recommend CMA for further genetic testing in fetuses with abnormal ultrasound findings.
In summary, this is the most extensive prenatal study using CMA technology for detailed molecular analysis of WBS cases. The prenatal presentation of WBS is quite variable, but IUGR with cardiovascular complications is the most common ultrasound performance. Although these early sonographic features are non-specific signs, with broad differential diagnosis, they warrant invasive testing. And we reported three cases combined with first-reported intrauterine phenotypes, which expand the intrauterine ultrasound phenotype of WBS in previous literature reports.
Availability of data and materials
The data that support the findings of this study are not publicly available due to their containing information that could compromise the privacy of research participants. Further inquiries can be directed to the corresponding author.
WBS chromosome region
Supravalvar aortic stenosis
Fluorescence in situ hybridization
Multiplex ligation-dependent probe amplification
Copy number variations
Quantitative fluorescent polymerase chain reaction
Single nucleotide polymorphic
Ventricular septal defect
Intrauterine growth retardation
Multicystic dysplastic kidney
Pulmonary artery stenosis
Tetralogy of Fallot
Right aortic arch
ISCN 2020: An International System for Human Cytogenomic Nomenclature (2020)[S]. McGowan-Jordan J, Ros JH, Sarah M, eds. Basel: Karger, 2020; also in Cytogenet Genome Res, 2020, 160:341–503. https://doi.org/10.1159/isbn.978-3-318-06867-2
Broder K, Reinhardt E, Ahern J, Lifton R, Tamborlane W, Pober B. Elevated ambulatory blood pressure in 20 subjects with Williams syndrome. Am J Med Genet. 1999;83(5):356–60.
Lashkari A, Smith AK, Graham JJ. Williams-Beuren syndrome: an update and review for the primary physician. Clin Pediatr (Phila). 1999;38(4):189–208.
Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362(3):239–52.
Collins RN. Cardiovascular disease in Williams syndrome. Curr Opin Pediatr. 2018;30(5):609–15.
Yuan SM. Congenital heart defects in Williams syndrome. Turk J Pediatr. 2017;59(3):225–32.
Morris CA, Demsey SA, Leonard CO, Dilts C, Blackburn BL. Natural history of Williams syndrome: physical characteristics. J Pediatr. 1988;113(2):318–26.
Ghaffari M, Tahmasebi BM, Kariminejad R, Saberi A. Genotype-phenotype correlation and the size of microdeletion or microduplication of 7q11.23 region in patients with Williams-Beuren syndrome. Ann Hum Genet. 2018;82(6):469–76.
Practice Bulletin No. 162: Prenatal diagnostic testing for genetic disorders. Obstet Gynecol. 2016;127(5):e108–22.
Yuan M, Deng L, Yang Y, Sun L. Intrauterine phenotype features of fetuses with Williams-Beuren syndrome and literature review. Ann Hum Genet. 2020;84(2):169–76.
Li C, Chen B, Zheng J, Cheng L, Song T, Guo F, et al. Prenatal diagnosis of BACs-on-beads assay in 3647 cases of amniotic fluid cells. Reprod Sci. 2019;26(7):1005–12.
Xi N, Zhang Z, Wang X, Sun L, Song X, Li S, et al. Prenatal diagnosis for a pregnant woman affected with Williams-Beuren syndrome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019;36(5):495–7.
Srinivasan S, Howley LW, Cuneo BF, Chatfield KC. In-utero idiopathic ductal constriction: a prenatal manifestation of Alagille and Williams syndrome arteriopathy. J Perinatol. 2018;38(11):1453–6.
Borrell A, Grande M, Meler E, Sabrià J, Mazarico E, Muñoz A, et al. Genomic microarray in fetuses with early growth restriction: a multicenter study. Fetal Diagn Ther. 2017;42(3):174–80.
Kobalka AJ, Mrak RE, Gunning WT. A case report of in utero Williams syndrome arterial malformation. Fetal Pediatr Pathol. 2017;36(6):452–6.
Zhu H, Lin S, Huang L, He Z, Huang X, Zhou Y, et al. Application of chromosomal microarray analysis in prenatal diagnosis of fetal growth restriction. Prenat Diagn. 2016;36(7):686–92.
Liu Y, Xu ZY, Wu WQ, Luo FW, Xie JS. Genetic and prenatal diagnosis for four families with Williams-Beuren syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17(12):1267–72.
Marcato L, Turolla L, Pompilii E, Dupont C, Gruchy N, De Toffol S, et al. Prenatal phenotype of Williams-Beuren syndrome and of the reciprocal duplication syndrome. Clin Case Rep. 2014;2(2):25–32.
Gruchy N, Decamp M, Richard N, Jeanne-Pasquier C, Benoist G, Mittre H, et al. Array CGH analysis in high-risk pregnancies: comparing DNA from cultured cells and cell-free fetal DNA. Prenat Diagn. 2012;32(4):383–8.
Popowski T, Vialard F, Leroy B, Bault JP, Molina-Gomes D. Williams-Beuren syndrome: the prenatal phenotype. Am J Obstet Gynecol. 2011;205(6):e6-8.
Krzeminska D, Steinfeld C, Cloez J, Vibert M, Chery M, Menzies D, et al. Prenatal diagnosis of Williams syndrome based on ultrasound signs. Prenatal Diagn. 2009;29(7):710–2.
Kontos H, Manolakos E, Malligiannis P, Plachouras N, Ploumis N, Mihalatos M, et al. Prenatal diagnosis of a fetus with 7q11.23 deletion detected by multiplex ligation-dependent probe amplification (MLPA) screening. Prenat Diagn. 2008;28(6):556–8.
von Dadelszen P, Chitayat D, Winsor EJ, Cohen H, MacDonald C, Taylor G, et al. De novo 46, XX, t(6;7)(q27;q11;23) associated with severe cardiovascular manifestations characteristic of supravalvular aortic stenosis and Williams syndrome. Am J Med Genet. 2000;90(4):270–5.
Zhen L, Fan SS, Huang LY, Pan M, Han J, Yang X, et al. Prenatal diagnosis of Wolf-Hirschhorn syndrome: ultrasonography and molecular karyotyping results. Eur J Obstet Gynecol Reprod Biol. 2018;225:19–21.
Schubert C. The genomic basis of the Williams-Beuren syndrome. Cell Mol Life Sci. 2009;66(7):1178–97.
Pober BR, Johnson M, Urban Z. Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. J Clin Invest. 2008;118(5):1606–15.
Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development. 2003;130(2):411–23.
Sforzini C, Milani D, Fossali E, Barbato A, Grumieri G, Bianchetti MG, et al. Renal tract ultrasonography and calcium homeostasis in Williams-Beuren syndrome. Pediatr Nephrol. 2002;17(11):899–902.
Pankau R, Partsch CJ, Winter M, Gosch A, Wessel A. Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome. Am J Med Genet. 1996;63(1):301–4.
Merla G, Brunetti-Pierri N, Micale L, Fusco C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum Genet. 2010;128(1):3–26.
Partsch CJ, Siebert R, Caliebe A, Gosch A, Wessel A, Pankau R. Sigmoid diverticulitis in patients with Williams-Beuren syndrome: relatively high prevalence and high complication rate in young adults with the syndrome. Am J Med Genet A. 2005;137(1):52–4.
We thank all the participants in this study.
This study was supported by the sub-project of the National Key R&D Program (2021YFC2701002), the National Natural Science Foundation of China (81801461, 81873836, 81771594), the Natural Science Foundation of Guangdong Province (2019A1515012034), science and technology planning project of Guangdong Province, China (Chinese charity number: 2016A020218003) and Science and Technology Program of Guangzhou China (Chinese charity number: 201607010341).
Ethics approval and consent to participate
This study was a retrospective one approved by our institutional review board/ethics committee.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Huang, R., Zhou, H., Fu, F. et al. Prenatal diagnosis of Williams-Beuren syndrome by ultrasound and chromosomal microarray analysis. Mol Cytogenet 15, 27 (2022). https://doi.org/10.1186/s13039-022-00604-2
- Williams-Beuren syndrome
- Prenatal diagnosis
- Chromosomal microarray analysis